{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T04:31:38Z","timestamp":1767846698002,"version":"3.49.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cancer"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1476-4598-13-60","type":"journal-article","created":{"date-parts":[[2014,3,19]],"date-time":"2014-03-19T04:03:30Z","timestamp":1395201810000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Toll-like receptor 9 agonist enhances anti-tumor immunity and inhibits tumor-associated immunosuppressive cells numbers in a mouse cervical cancer model following recombinant lipoprotein therapy"],"prefix":"10.1186","volume":"13","author":[{"given":"Li-Sheng","family":"Chang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chih-Hsiang","family":"Leng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Chen","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiao-Chieh","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hsin-Wei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hai-Mei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shih-Jen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,3,19]]},"reference":[{"key":"1285_CR1","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1053\/j.seminoncol.2012.02.002","volume":"39","author":"JA Berzofsky","year":"2012","unstructured":"Berzofsky JA, Terabe M, Wood LV: Strategies to use immune modulators in therapeutic vaccines against cancer. Semin Oncol. 2012, 39: 348-357. 10.1053\/j.seminoncol.2012.02.002","journal-title":"Semin Oncol"},{"key":"1285_CR2","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.1158\/0008-5472.CAN-12-3932","volume":"73","author":"JG Aerts","year":"2013","unstructured":"Aerts JG, Hegmans JP: Tumor-specific cytotoxic T cells are crucial for efficacy of immunomodulatory antibodies in patients with lung cancer. Cancer Res. 2013, 73: 2381-2388. 10.1158\/0008-5472.CAN-12-3932","journal-title":"Cancer Res"},{"key":"1285_CR3","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1172\/JCI18044","volume":"111","author":"S Chouaib","year":"2003","unstructured":"Chouaib S: Integrating the quality of the cytotoxic response and tumor susceptibility into the design of protective vaccines in tumor immunotherapy. J Clin Invest. 2003, 111: 595-597. 10.1172\/JCI18044","journal-title":"J Clin Invest"},{"key":"1285_CR4","doi-asserted-by":"publisher","first-page":"4015","DOI":"10.1172\/JCI45862","volume":"121","author":"T Lu","year":"2011","unstructured":"Lu T, Ramakrishnan R, Altiok S, Youn JI, Cheng P, Celis E, Pisarev V, Sherman S, Sporn MB, Gabrilovich D: Tumor-infiltrating myeloid cells induce tumor cell resistance to cytotoxic T cells in mice. J Clin Invest. 2011, 121: 4015-4029. 10.1172\/JCI45862","journal-title":"J Clin Invest"},{"key":"1285_CR5","doi-asserted-by":"publisher","first-page":"5048","DOI":"10.4049\/jimmunol.1000134","volume":"185","author":"E James","year":"2010","unstructured":"James E, Yeh A, King C, Korangy F, Bailey I, Boulanger DS, Van den Eynde BJ, Murray N, Elliott TJ: Differential suppression of tumor-specific CD8+ T cells by regulatory T cells. J Immunol. 2010, 185: 5048-5055. 10.4049\/jimmunol.1000134","journal-title":"J Immunol"},{"key":"1285_CR6","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1097\/CCO.0b013e32831bc38a","volume":"21","author":"MJ Pittet","year":"2009","unstructured":"Pittet MJ: Behavior of immune players in the tumor microenvironment. Curr Opin Opthalmol. 2009, 21: 53-59.","journal-title":"Curr Opin Opthalmol"},{"key":"1285_CR7","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.it.2011.12.001","volume":"33","author":"B Ruffell","year":"2012","unstructured":"Ruffell B, Affara NI, Coussens LM: Differential macrophage programming in the tumor microenvironment. Trends Immunol. 2012, 33: 119-126. 10.1016\/j.it.2011.12.001","journal-title":"Trends Immunol"},{"key":"1285_CR8","doi-asserted-by":"crossref","first-page":"990","DOI":"10.4049\/jimmunol.159.2.990","volume":"159","author":"MR Young","year":"1997","unstructured":"Young MR, Wright MA, Pandit R: Myeloid differentiation treatment to diminish the presence of immune-suppressive CD34+ cells within human head and neck squamous cell carcinomas. J Immunol. 1997, 159: 990-996.","journal-title":"J Immunol"},{"key":"1285_CR9","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1002\/ijc.2910440220","volume":"44","author":"JL Subiza","year":"1989","unstructured":"Subiza JL, Vinuela JE, Rodriguez R, Gil J, Figueredo MA, De La Concha EG: Development of splenic natural suppressor (NS) cells in Ehrlich tumor-bearing mice. Int J Cancer. 1989, 44: 307-314. 10.1002\/ijc.2910440220","journal-title":"Int J Cancer"},{"key":"1285_CR10","first-page":"606","volume":"9","author":"AM Wolf","year":"2003","unstructured":"Wolf AM, Wolf D, Steurer M, Gastl G, Gunsilius E, Grubeck-Loebenstein B: Increase of regulatory T cells in the peripheral blood of cancer patients. Clin Cancer Res. 2003, 9: 606-612.","journal-title":"Clin Cancer Res"},{"key":"1285_CR11","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1038\/sj.bjc.6602407","volume":"92","author":"C Schaefer","year":"2005","unstructured":"Schaefer C, Kim GG, Albers A, Hoermann K, Myers EN, Whiteside TL: Characteristics of CD4\u2009+\u2009CD25+ regulatory T cells in the peripheral circulation of patients with head and neck cancer. Br J Cancer. 2005, 92: 913-920. 10.1038\/sj.bjc.6602407","journal-title":"Br J Cancer"},{"key":"1285_CR12","doi-asserted-by":"publisher","first-page":"2756","DOI":"10.4049\/jimmunol.169.5.2756","volume":"169","author":"UK Liyanage","year":"2002","unstructured":"Liyanage UK, Moore TT, Joo HG, Tanaka Y, Herrmann V, Doherty G, Drebin JA, Strasberg SM, Eberlein TJ, Goedegebuure PS, Linehan DC: Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma. J Immunol. 2002, 169: 2756-2761.","journal-title":"J Immunol"},{"key":"1285_CR13","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1038\/nm1093","volume":"10","author":"TJ Curiel","year":"2004","unstructured":"Curiel TJ, Coukos G, Zou L, Alvarez X, Cheng P, Mottram P, Evdemon-Hogan M, Conejo-Garcia JR, Zhang L, Burow M, Zhu Y, Wei S, Kryczek I, Danie B, Gordon A, Myers L, Lackner A, Disis ML, Knutson KL, Chen L, Zou W: Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med. 2004, 10: 942-949. 10.1038\/nm1093","journal-title":"Nat Med"},{"key":"1285_CR14","doi-asserted-by":"publisher","first-page":"3623","DOI":"10.1172\/JCI25947","volume":"115","author":"J Dannull","year":"2005","unstructured":"Dannull J, Su Z, Rizzieri D, Yang BK, Coleman D, Yancey D, Zhang A, Dahm P, Chao N, Gilboa E, Vieweg J: Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cells. J Clin Invest. 2005, 115: 3623-3633. 10.1172\/JCI25947","journal-title":"J Clin Invest"},{"key":"1285_CR15","doi-asserted-by":"publisher","first-page":"3192","DOI":"10.1182\/blood-2007-06-094615","volume":"110","author":"MT Litzinger","year":"2007","unstructured":"Litzinger MT, Fernando R, Curiel TJ, Grosenbach DW, Schlom J, Palena C: IL-2 immunotoxin denileukin diftitox reduces regulatory T cells and enhances vaccine-mediated T-cell immunity. Blood. 2007, 110: 3192-3201. 10.1182\/blood-2007-06-094615","journal-title":"Blood"},{"key":"1285_CR16","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1093\/intimm\/13.7.933","volume":"13","author":"O Takeuchi","year":"2001","unstructured":"Takeuchi O, Kawai T, Muhlradt PF, Morr M, Radolf JD, Zychlinsky A, Takeda K, Akira S: Discrimination of bacterial lipoproteins by Toll-like receptor 6. Int Immunol. 2001, 13: 933-940. 10.1093\/intimm\/13.7.933","journal-title":"Int Immunol"},{"key":"1285_CR17","doi-asserted-by":"publisher","first-page":"2444","DOI":"10.4049\/jimmunol.166.4.2444","volume":"166","author":"CJ Hertz","year":"2001","unstructured":"Hertz CJ, Kiertscher SM, Godowski PJ, Bouis DA, Norgard MV, Roth MD, Modlin RL: Microbial lipopeptides stimulate dendritic cell maturation via Toll-like receptor 2. J Immunol. 2001, 166: 2444-2450.","journal-title":"J Immunol"},{"key":"1285_CR18","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1016\/j.molimm.2010.04.012","volume":"47","author":"CH Leng","year":"2010","unstructured":"Leng CH, Chen HW, Chang LS, Liu HH, Liu HY, Sher YP, Chang YW, Lien SP, Huang TY, Chen MY, Chou AH, Chong P, Liu SJ: A recombinant lipoprotein containing an unsaturated fatty acid activates NF-kappaB through the TLR2 signaling pathway and induces a differential gene profile from a synthetic lipopeptide. Mole Immunol. 2010, 47: 2015-2021. 10.1016\/j.molimm.2010.04.012.","journal-title":"Mole Immunol"},{"key":"1285_CR19","doi-asserted-by":"publisher","first-page":"e40970","DOI":"10.1371\/journal.pone.0040970","volume":"7","author":"CY Huang","year":"2012","unstructured":"Huang CY, Chen JJ, Shen KY, Chang LS, Yeh YC, Chen IH, Chong P, Liu SJ, Leng CH: Recombinant lipidated HPV E7 induces a Th-1-biased immune response and protective immunity against cervical cancer in a mouse model. PLoS One. 2012, 7: e40970- 10.1371\/journal.pone.0040970","journal-title":"PLoS One"},{"key":"1285_CR20","first-page":"1165","volume":"118","author":"C Liu","year":"2008","unstructured":"Liu C, Lou Y, Lizee G, Qin H, Liu S, Rabinovich B, Kim GJ, Wang YH, Ye Y, Sikora AG, Overwijk WW, Liu YJ, Wang G, Hwu P: Plasmacytoid dendritic cells induce NK cell-dependent, tumor antigen-specific T cell cross-priming and tumor regression in mice. J Clin Invest. 2008, 118: 1165-1175.","journal-title":"J Clin Invest"},{"key":"1285_CR21","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1038\/ni.1937","volume":"11","author":"SK Biswas","year":"2010","unstructured":"Biswas SK, Mantovani A: Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. Nat Immunol. 2010, 11: 889-896. 10.1038\/ni.1937","journal-title":"Nat Immunol"},{"key":"1285_CR22","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1038\/ni1223","volume":"6","author":"G Napolitani","year":"2005","unstructured":"Napolitani G, Rinaldi A, Bertoni F, Sallusto F, Lanzavecchia A: Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1-polarizing program in dendritic cells. Nat Immunol. 2005, 6: 769-776. 10.1038\/ni1223","journal-title":"Nat Immunol"},{"key":"1285_CR23","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/j.humimm.2007.08.001","volume":"68","author":"D Krumbiegel","year":"2007","unstructured":"Krumbiegel D, Zepp F, Meyer CU: Combined Toll-like receptor agonists synergistically increase production of inflammatory cytokines in human neonatal dendritic cells. Hum Immunol. 2007, 68: 813-822. 10.1016\/j.humimm.2007.08.001","journal-title":"Hum Immunol"},{"key":"1285_CR24","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/1471-2172-10-43","volume":"10","author":"C Grossmann","year":"2009","unstructured":"Grossmann C, Tenbusch M, Nchinda G, Temchura V, Nabi G, Stone GW, Kornbluth RS, Uberla K: Enhancement of the priming efficacy of DNA vaccines encoding dendritic cell-targeted antigens by synergistic toll-like receptor ligands. BMC Immunol. 2009, 10: 43- 10.1186\/1471-2172-10-43","journal-title":"BMC Immunol"},{"key":"1285_CR25","doi-asserted-by":"publisher","first-page":"16260","DOI":"10.1073\/pnas.0805325105","volume":"105","author":"Q Zhu","year":"2008","unstructured":"Zhu Q, Egelston C, Vivekanandhan A, Uematsu S, Akira S, Klinman DM, Belyakov IM, Berzofsky JA: Toll-like receptor ligands synergize through distinct dendritic cell pathways to induce T cell responses: implications for vaccines. Proc Natl Acad Sci U S A. 2008, 105: 16260-16265. 10.1073\/pnas.0805325105","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1285_CR26","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.4049\/jimmunol.1101304","volume":"188","author":"Y Shirota","year":"2012","unstructured":"Shirota Y, Shirota H, Klinman DM: Intratumoral injection of CpG oligonucleotides induces the differentiation and reduces the immunosuppressive activity of myeloid-derived suppressor cells. J Immunol. 2012, 188: 1592-1599. 10.4049\/jimmunol.1101304","journal-title":"J Immunol"},{"key":"1285_CR27","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1016\/j.biomaterials.2012.09.062","volume":"34","author":"Z Huang","year":"2013","unstructured":"Huang Z, Yang Y, Jiang Y, Shao J, Sun X, Chen J, Dong L, Zhang J: Anti-tumor immune responses of tumor-associated macrophages via toll-like receptor 4 triggered by cationic polymers. Biomaterials. 2013, 34: 746-755. 10.1016\/j.biomaterials.2012.09.062","journal-title":"Biomaterials"},{"key":"1285_CR28","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.canlet.2013.01.001","volume":"331","author":"J Peng","year":"2013","unstructured":"Peng J, Tsang JY, Li D, Niu N, Ho DH, Lau KF, Lui VC, Lamb JR, Chen Y, Tam PK: Inhibition of TGF-beta signaling in combination with TLR7 ligation re-programs a tumoricidal phenotype in tumor-associated macrophages. Cancer Lett. 2013, 331: 239-249. 10.1016\/j.canlet.2013.01.001","journal-title":"Cancer Lett"},{"key":"1285_CR29","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.4049\/jimmunol.1002320","volume":"186","author":"Y Zhang","year":"2011","unstructured":"Zhang Y, Luo F, Cai Y, Liu N, Wang L, Xu D, Chu Y: TLR1\/TLR2 agonist induces tumor regression by reciprocal modulation of effector and regulatory T cells. J Immunol. 2011, 186: 1963-1969. 10.4049\/jimmunol.1002320","journal-title":"J Immunol"},{"key":"1285_CR30","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1002\/ijc.25399","volume":"128","author":"C Jacobs","year":"2011","unstructured":"Jacobs C, Duewell P, Heckelsmiller K, Wei J, Bauernfeind F, Ellermeier J, Kisser U, Bauer CA, Dauer M, Eigler A, Maraskovsky E, Endres S, Schnurr M: An ISCOM vaccine combined with a TLR9 agonist breaks immune evasion mediated by regulatory T cells in an orthotopic model of pancreatic carcinoma. Int J Cancer. 2011, 128: 897-907. 10.1002\/ijc.25399","journal-title":"Int J Cancer"},{"key":"1285_CR31","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1182\/blood-2005-10-4015","volume":"108","author":"T Warger","year":"2006","unstructured":"Warger T, Osterloh P, Rechtsteiner G, Fassbender M, Heib V, Schmid B, Schmitt E, Schild H, Radsak MP: Synergistic activation of dendritic cells by combined Toll-like receptor ligation induces superior CTL responses in vivo. Blood. 2006, 108: 544-550. 10.1182\/blood-2005-10-4015","journal-title":"Blood"},{"key":"1285_CR32","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1172\/JCI39293","volume":"120","author":"Q Zhu","year":"2010","unstructured":"Zhu Q, Egelston C, Gagnon S, Sui Y, Belyakov IM, Klinman DM, Berzofsky JA: Using 3 TLR ligands as a combination adjuvant induces qualitative changes in T cell responses needed for antiviral protection in mice. J Clin Invest. 2010, 120: 607-616. 10.1172\/JCI39293","journal-title":"J Clin Invest"},{"key":"1285_CR33","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1158\/1078-0432.CCR-10-2672","volume":"17","author":"C Zoglmeier","year":"2011","unstructured":"Zoglmeier C, Bauer H, Norenberg D, Wedekind G, Bittner P, Sandholzer N, Rapp M, Anz D, Endres S, Bourquin C: CpG blocks immunosuppression by myeloid-derived suppressor cells in tumor-bearing mice. Clin Cancer Res. 2011, 17: 1765-1775. 10.1158\/1078-0432.CCR-10-2672","journal-title":"Clin Cancer Res"},{"key":"1285_CR34","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.imlet.2006.12.007","volume":"108","author":"DF LaRosa","year":"2007","unstructured":"LaRosa DF, Gelman AE, Rahman AH, Zhang J, Turka LA, Walsh PT: CpG DNA inhibits CD4\u2009+\u2009CD25+ Treg suppression through direct MyD88-dependent costimulation of effector CD4+ T cells. Immunol Lett. 2007, 108: 183-188. 10.1016\/j.imlet.2006.12.007","journal-title":"Immunol Lett"},{"key":"1285_CR35","doi-asserted-by":"publisher","first-page":"4391","DOI":"10.1158\/1078-0432.CCR-09-0489","volume":"15","author":"AP Lepique","year":"2009","unstructured":"Lepique AP, Daghastanli KR, Cuccovia IM, Villa LL: HPV16 tumor associated macrophages suppress antitumor T cell responses. Clin Cancer Res. 2009, 15: 4391-4400. 10.1158\/1078-0432.CCR-09-0489","journal-title":"Clin Cancer Res"},{"key":"1285_CR36","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/S1471-4906(02)02302-5","volume":"23","author":"A Mantovani","year":"2002","unstructured":"Mantovani A, Sozzani S, Locati M, Allavena P, Sica A: Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol. 2002, 23: 549-555. 10.1016\/S1471-4906(02)02302-5","journal-title":"Trends Immunol"},{"key":"1285_CR37","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1089\/ten.tea.2007.0264","volume":"14","author":"SF Badylak","year":"2008","unstructured":"Badylak SF, Valentin JE, Ravindra AK, McCabe GP, Stewart-Akers AM: Macrophage phenotype as a determinant of biologic scaffold remodeling. Tissue Eng Part A. 2008, 14: 1835-1842. 10.1089\/ten.tea.2007.0264","journal-title":"Tissue Eng Part A"},{"key":"1285_CR38","doi-asserted-by":"crossref","first-page":"3437","DOI":"10.1158\/0008-5472.CAN-04-4262","volume":"65","author":"C Guiducci","year":"2005","unstructured":"Guiducci C, Vicari AP, Sangaletti S, Trinchieri G, Colombo MP: Redirecting in vivo elicited tumor infiltrating macrophages and dendritic cells towards tumor rejection. Cancer Res. 2005, 65: 3437-3446.","journal-title":"Cancer Res"},{"key":"1285_CR39","first-page":"21","volume":"56","author":"KY Lin","year":"1996","unstructured":"Lin KY, Guarnieri FG, Staveley-O\u2019Carroll KF, Levitsky HI, August JT, Pardoll DM, Wu TC: Treatment of established tumors with a novel vaccine that enhances major histocompatibility class II presentation of tumor antigen. Cancer Res. 1996, 56: 21-26.","journal-title":"Cancer Res"},{"key":"1285_CR40","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1182\/blood.V96.9.3029","volume":"96","author":"K Brasel","year":"2000","unstructured":"Brasel K, De Smedt T, Smith JL, Maliszewski CR: Generation of murine dendritic cells from flt3-ligand-supplemented bone marrow cultures. Blood. 2000, 96: 3029-3039.","journal-title":"Blood"},{"key":"1285_CR41","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1158\/1535-7163.MCT-10-0827","volume":"10","author":"YP Sher","year":"2011","unstructured":"Sher YP, Liu SJ, Chang CM, Lien SP, Chen CH, Han Z, Li LY, Chen JS, Wu CW, Hung MC: Cancer-targeted BikDD gene therapy elicits protective antitumor immunity against lung cancer. Mol Cancer Ther. 2011, 10: 637-647. 10.1158\/1535-7163.MCT-10-0827","journal-title":"Mol Cancer Ther"}],"container-title":["Molecular Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1476-4598-13-60.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T08:56:52Z","timestamp":1689065812000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecular-cancer.biomedcentral.com\/articles\/10.1186\/1476-4598-13-60"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3,19]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["1285"],"URL":"https:\/\/doi.org\/10.1186\/1476-4598-13-60","relation":{},"ISSN":["1476-4598"],"issn-type":[{"value":"1476-4598","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,19]]},"assertion":[{"value":"15 January 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"60"}}